Treating Severe Hyperkalemia with Renal Replacement Therapy in Acute Kidney Failure Due To Rhabdomyolysis

Authors

  • Alfred Ibrahimi Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Saimir Kuci Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Ervin Bejko Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Stavri Llazo Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Esmerilda Bulku Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Diana Dhimitri Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana
  • Ilir Ohri Department of Anesthesiology and Intensive Care, Tirana University Hospital “Mother Thereza”, Tirana

DOI:

https://doi.org/10.3889/oamjms.2014.053

Keywords:

Hyperkalemia, Myoglobinuria, Rhabdomyolisis, Acute renal failure, CRRT.

Abstract

Rhabdomyolysis and myoglobinuria are the main cause of the acute renal failure. Hyperkalemia is life threating complication of rhabdomyolisis due to massive cell destruction. We report a case of very severe hyperkalemia treated successfully with high volume hemodiafiltration (CVVHDF).

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007;2(3):210-8.

O'Connor FG, Deuster PA. Rhabdomyolysis. In Cecil Medicine, Goldman L, Ausiello D, Eds., chapter 114, Saunders Elsevier: Philadelphia, Pa, USA, 23rd edition, 2007.

Remuzzi G, Perico N, DeBroe ME. Acute kidney injury, in Brenner and Rector's the Kidney, B. M. Brenner, Ed., chapter 29, Saunders Elsevier, Philadelphia: Pa, USA, 8th edition, 2007.

Naka T, Jones D, Baldwin I et al. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Critical Care. 2005;9(2): R90–R95.

Ronco C. Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance. Critical Care. 2005;9(2:141–142, 2005.

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical care. 2004; 8(4):R204–R212, 2004.

Brendolan A, D'Intini V, Ricci Z, Bonello M, Ratanarat R, Salvatori G, Bordoni V, De Cal M, Andrikos E, Ronco C. Pulse high volume hemofiltration. Int J Artif Organs. 2004;27(5):398-403.

Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med. 2001;27(5):803-11.

Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, Roberts LJ 2nd. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem. 1998;273(48):31731-7.

Zager RA, Gamelin LM. Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol. 1989;256(3 Pt 2):F446-55.

Downloads

Published

2014-06-15

How to Cite

1.
Ibrahimi A, Kuci S, Bejko E, Llazo S, Bulku E, Dhimitri D, Ohri I. Treating Severe Hyperkalemia with Renal Replacement Therapy in Acute Kidney Failure Due To Rhabdomyolysis. Open Access Maced J Med Sci [Internet]. 2014 Jun. 15 [cited 2022 Aug. 14];2(2):313-5. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2014.053

Issue

Section

C- Case Reports

Most read articles by the same author(s)